Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCR
3201
DELISTED
Synchronoss Technologies
SNCR
| $4.65M | ﹤0.01% |
427,365
+1,655
| +0.4% | +$16.4K |
|
3202
Prairie Operating Co
PROP
$69.8M
| $4.65M | ﹤0.01% |
869,876
+412,385
| +90% | +$3.01M |
|
3203
SES AI
SES
$203M
| $4.65M | ﹤0.01% |
8,921,766
+1,074,450
| +14% | +$988K |
|
3204
Nkarta
NKTX
$150M
| $4.65M | ﹤0.01% |
2,525,107
-5,673
| -0.2% | -$11.6K |
|
|
IRBT
3205
DELISTED
iRobot
IRBT
| $4.62M | ﹤0.01% |
1,709,952
+23,822
| +1% | +$172K |
|
3206
Friedman Industries
FRD
$240M
| $4.61M | ﹤0.01% |
309,774
+353
| +0.1% | +$5.52K |
|
3207
Copel
ELPC
$8.71B
| $4.6M | ﹤0.01% |
682,342
| – | – |
|
3208
Legend Biotech
LEGN
$3.59B
| $4.6M | ﹤0.01% |
135,506
+7,013
| +5% | +$252K |
|
3209
Achieve Life Sciences
ACHV
$659M
| $4.58M | ﹤0.01% |
1,717,014
-32,777
| -2% | -$102K |
|
3210
Consumer Portfolio Services
CPSS
$202M
| $4.58M | ﹤0.01% |
528,765
-756
| -0.1% | -$7.86K |
|
3211
1stdibs.com
DIBS
$149M
| $4.57M | ﹤0.01% |
1,504,661
-14,248
| -0.9% | -$51.1K |
|
3212
Nuvectis Pharma
NVCT
$678M
| $4.57M | ﹤0.01% |
467,419
+142,122
| +44% | +$1.02M |
|
3213
ProKidney
PROK
$316M
| $4.57M | ﹤0.01% |
5,211,823
-63,882
| -1% | -$88.7K |
|
3214
Viking Holdings
VIK
$46.6B
| $4.56M | ﹤0.01% |
114,693
+887
| +0.8% | +$40.9K |
|
3215
Ohio Valley Banc Corp
OVBC
$198M
| $4.55M | ﹤0.01% |
174,819
+115,526
| +195% | +$3.06M |
|
3216
Genasys
GNSS
$76.1M
| $4.54M | ﹤0.01% |
2,001,704
+58,947
| +3% | +$163K |
|
3217
KVH Industries
KVHI
$181M
| $4.54M | ﹤0.01% |
857,742
| – | – |
|
3218
Personalis
PSNL
$1.35B
| $4.53M | ﹤0.01% |
1,290,591
-444,295
| -26% | -$2.11M |
|
3219
Hurco Companies Inc
HURC
$135M
| $4.52M | ﹤0.01% |
291,137
| – | – |
|
3220
Pliant Therapeutics
PLRX
$64.4M
| $4.5M | ﹤0.01% |
3,334,575
+105,820
| +3% | +$642K |
|
3221
EverCommerce
EVCM
$2.18B
| $4.5M | ﹤0.01% |
446,251
-12,331
| -3% | -$126K |
|
|
ADVM
3222
DELISTED
Adverum Biotechnologies
ADVM
| $4.5M | ﹤0.01% |
1,029,326
-1,756
| -0.2% | -$7.91K |
|
3223
KORU Medical Systems
KRMD
$189M
| $4.48M | ﹤0.01% |
1,764,007
+6,482
| +0.4% | +$24.1K |
|
3224
MoonLake Immunotherapeutics
MLTX
$1.57B
| $4.45M | ﹤0.01% |
114,018
-1,398
| -1% | -$60.2K |
|
3225
Atossa Therapeutics
ATOS
$20.6M
| $4.43M | ﹤0.01% |
439,061
-2,204
| -0.5% | -$26.8K |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.